REEDOS 5 lamotrigine 5 mg dispersible/chewable tablets bottle

Active ingredient:

lamotrigine, Quantity: 5 mg

Available from:

Strides Pharma Science Pty Ltd

INN (International Name):

Lamotrigine

Pharmaceutical form:

Tablet, dispersible

Composition:

Excipient Ingredients: povidone; magnesium stearate; sucralose; polacrilin potassium; microcrystalline cellulose; magnesium carbonate hydrate; Flavour

Administration route:

Oral

Units in package:

56, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,There is extensive experience with Lamotrigine used initially as ?add-on? therapy. The use of Lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

Product summary:

Visual Identification: White to off-white capsule shaped uncoated tablets debossed with 'H' on one side and '81' on other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2012-05-03